Anguk Yakpum Tobicom

The Nation's First Edible Eye Supplement... Easy Digestion and Absorption with Plant-Based Ingredients View original image

Anguk Pharmaceutics launched Korea's first oral eye supplement, 'Tobicom,' in 1981. As the use of digital media has increased, the time spent using eyes has grown, leading to continuous growth in the eye supplement market.


As of 2019, the eye supplement market is valued at 120 billion KRW. The main sales channels have diversified from pharmacies to online platforms and health & beauty (H&B) shops.


The company transitioned Tobicom from a general medicine to a health functional food, taking on a new challenge in the eye supplement market.


Tobicom contains Haematococcus (100% of the daily recommended amount), which helps improve eye fatigue?an essential need for modern people?and Vitamin A (143% of the nutritional standard), necessary for visual adaptation in dark environments, along with four types of Vitamin B complex including niacin and pantothenic acid, which are required for energy production.


An Anguk Pharmaceutics brand representative stated, "While typical capsule types use gelatin derived from cowhide or pigskin, Tobicom uses plant-based ingredients, making it easier to digest and absorb in the body and allowing safe storage against external environmental changes such as temperature and humidity. We recommend Tobicom to protect tired eyes with just one capsule a day."



Tobicom is available for purchase on the official Anguk Pharmaceutics online store.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing